Global Pollen Allergy Industry is poised to grow at a CAGR of 4.2%, reaching US$ 8,828.6 million by 2033, according to FMI

The global pollen allergy industry is currently valued at US$ 5850.8 Million in 2023 and is anticipated to expand at a CAGR of 4.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 8828.6 Million by 2033.

The rise in number of patients suffering from pollen-based allergies and more precisely hay fever drive the growth of the market. Moreover, growing number of patients especially children are another contributor for escalating the global pollen allergy industry. Rapid urbanization in the advancing countries is the major factor that boost the growth of the pollen allergies market in the forecast period.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-16236

The increase in greenhouse gas can result in pollen-induced reparative disease which is further estimated to cushion the growth of the pollen allergies market.

Corticosteroids dominated the pollen allergy industry in terms of revenue share as corticosteroids are mostly used as the first line of treatment is also expected to contribute towards the market growth.

North America has dominated the global pollen allergy industry due to the increased incidence rate of allergies and awareness of therapy. Europe is expected to have the second-largest market for the global pollen allergy industry. Increasing awareness among people about diseases is also a major factor that may boost the growth of the market in this region.

Key Takeaways from the Market Study:

• As of 2023, the pollen allergy industry was valued at US$ 5850.8 Million
• From 2023 to 2033, the pollen allergy industry is poised to grow at a 4.2% CAGR
• By 2033, the pollen allergy industry is slated to reach a valuation of US$ 8828.6 Million
• Based on therapeutic drug class, Corticosteroids dominated the pollen allergy industry in 2023 with a revenue share of 35.5%.
• China is poised to yield a CAGR of 3.8% with respect pollen allergy in 2033

“Technological advancement in healthcare and increase in the prevalence of allergic rhinitis and rise in the number of patients especially children suffering from pollen allergies expected to radically transform the pollen allergy industry in the coming years,” comments an analyst at FMI.

Connect With Our Analyst To Address Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-16236

Competitive Landscape:

Some of the leading manufacturers and players assessed in the global pollen allergy industry are

• bioMerieux SA
• HOB Biotech Group Corp Ltd
• Alcon
• HYCOR Biomedical, Inc
• Immunomic Therapeutics
• Quest Diagnostics Incorporated
• Omega Diagnostics Group PLC
• Siemens Healthcare Private Limited
• Stallergenes Greer
• Lincoln Diagnostics, Inc.

Manufacturers and players functional in the global pollen allergy industry are adopting various corporate growth strategies such as new product launches, mergers and acquisitions, and geographical expansion, among others.

• In July 2022 – Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI real-world study. Presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) congress in Prague (Czech Republic), the real-world study confirmed significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis.
• Lincoln Diagnostics offers a painless option for skin allergy testing with the Multi-Test PC (pain control). This test still provides high sensitivity, high specificity, and low variability in results but with virtually no pain.

Unlocking the Power of Personalization: Embrace Customization in Our Latest Report! https://www.futuremarketinsights.com/customization-available/rep-gb-16236

Key Segments Covered in the Pollen Allergy Industry Survey:

Pollen allergy industry by Product Type:

• Instruments
• Consumables
• Services

Pollen allergy industry by Allergen Type:

• Food
• Inhaled
• Drug
• Other

Pollen allergy industry by Therapeutics Drug class:

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anticholinergics
• Immunomodulators
• Auto injectable Epinephrine
• Immunotherapy

Pollen allergy industry by End-User:

• Diagnostic Laboratories
• Hospitals

Pollen allergy industry by Region:

• North America Pollen allergy industry
• Latin America Pollen allergy industry
• Europe Pollen allergy industry
• South Asia Pollen allergy industry
• East Asia Pollen allergy industry
• Oceania Pollen allergy industry
• MEA Pollen allergy industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube